Conducted legal research and worked with expert witnesses on antitrust litigation relating to healthcare mergers, including analysis of the 2020 Vertical Merger Guidelines and changes to federal anti-kickback rules. Drafted advocacy brief analyzing U.S. state legislation on prescription drug price transparency.

Lead business strategy across multiple products for Bay Area non-profit that makes FDA / CE certified medical devices. We identify critical patient needs in global health then design the products, build distribution systems and forge commercial partnerships to bring life-saving therapies to market in the world's lowest-income places. - Negotiated a distribution agreement to deliver a critical neonatal jaundice therapy to every tertiary hospital in Rwanda- Led an intensive redesign project, presenting risks and timelines to senior management and the board, managing strategic communications with customers and regulators, and working intensively with engineers and our manufacturing partner to successfully bring a product back to market- Traveled to more than a dozen countries, building relationships with clinicians and value chain partners across East Africa, South Asia, East Asia, and South America- Built sales projections and financial models for multiple products- Directly managed teams of up to four staff and $500K-$1MM annual budgets over multiple years- Mentored student teams at Stanford's Design for Extreme Affordability program- Guest lectured at UCLA Anderson School of Management and La Salle University School of Business on design thinking in global health.

Coordinator for the ChinaFAQs project, which brought together policymakers and research on China, climate change, and energy in Washington DC.